{
  "nctId": "NCT03557541",
  "briefTitle": "Sardine-enriched Diet for Prevention Type 2 Diabetes",
  "officialTitle": "Sardine-enriched Diet for Prevention Type 2 Diabetes in Elderly and Prediabetic Population",
  "protocolDocument": {
    "nctId": "NCT03557541",
    "filename": "Prot_SAP_001.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2013-11-28",
    "uploadDate": "2018-07-18T10:00",
    "size": 238055,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03557541/document/Prot_SAP_001.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 182,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2014-05",
    "completionDate": "2017-07",
    "primaryCompletionDate": "2017-07",
    "firstSubmitDate": "2018-03-21",
    "firstPostDate": "2018-06-15"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* glycaemia between 100-125 md / dL or â‰¥5.7% HbA1c\n\nExclusion Criteria:\n\n* treatment with oral antidiabetic drugs\n* any nutritional education to prevent T2D\n* Suspect or known hypersensitivity to sardine or related fish\n* Chronic treatment with oral steroids and / or AINES\n* Treatment with oral antidiabetic agents and / or insulin\n* Treatment with immunosuppressive drugs\n* Diagnosis of active neoplasm\n* Diagnosis of HIV or AIDS\n* Abnormal liver profile (\\> 6 times normal values)\n* Diagnosis of Acute Psychiatric Sdr\n* Presence of serious acute concomitant disease, which it requires more than 7 days of recovery.\n* Major cardiovascular event (stroke, myocardial infarction) in the month prior to randomization.\n* Any other condition that the investigator considers to be inoperative so that the subject conducts the study.",
    "healthyVolunteers": true,
    "sex": "ALL",
    "minimumAge": "65 Years",
    "stdAges": [
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "type 2 diabetes new onset",
        "description": "incidence of new diagnosis of type 2 diabetes",
        "timeFrame": "Change from Baseline at 12 months"
      }
    ],
    "secondary": [
      {
        "measure": "adiponectin",
        "description": "adiponectin levels",
        "timeFrame": "Change from Baseline at 12 months"
      },
      {
        "measure": "quantification of gut microbiota populations",
        "description": "quantification by q-PCR",
        "timeFrame": "Change from Baseline at 12 months"
      },
      {
        "measure": "gene expression",
        "description": "relative expression related genes by RT q-PCR (Real Time Quantitative Reverse transcription polymerase chain reaction)",
        "timeFrame": "Change from Baseline at 12 months"
      },
      {
        "measure": "metabolomics study of dietary biomarkers and health biomarkers [(1) Fatty acyls, bile acids, steroids and lysoglycerophospholipids, (2) Glycerolipids, glycerophospholipids, sterol lipids and sphingolipids, (3) Amino acids.]",
        "description": "endogenous metabolic profiles of serum samples will be studied using ultra-high performance liquid chromatography - mass spectrometry (UHPLC-MS). The same unit for measurements \\[log2 (fold change)\\]",
        "timeFrame": "Change from Baseline at 12 months"
      },
      {
        "measure": "glucose homeostasis",
        "description": "glucose (mg/dl)",
        "timeFrame": "Change from Baseline at 12 months"
      },
      {
        "measure": "insulin levels",
        "description": "insulin (mU/L)",
        "timeFrame": "Change from Baseline at 12 months"
      },
      {
        "measure": "HOMA-IR (homeostasis model assessment insulin resistance)",
        "description": "insulin resistance index",
        "timeFrame": "Change from Baseline at 12 months"
      },
      {
        "measure": "HOMA-B (homeostasis model assessment B cell function)",
        "description": "B cella function",
        "timeFrame": "Change from Baseline at 12 months"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 8,
      "otherCount": 0,
      "totalCount": 9
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 64,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:29:09.163Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}